🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06730321
Recruiting Observational

Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

NCT06730321 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai 6th People's Hospital
Phase
Observational
Started
2024-12-12
Last updated
2026-05-07

Condition(s) studied

Thyroid CancerThyroid NoduleThyroid DiseasesThyroid Cancer, PapillaryThyroid Cancer, Follicular

Investigational drug(s) / intervention(s)

Observations on clinicopathological factors influencing the assessment score of surgery

Observations on clinicopathological factors influencing the assessment score of surgery: Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data

Study summary

To develop and validate a structured scoring tool (robotic thyroidectomy assessment score, RTAS) for assessing and quantifying surgical performance in robotic thyroidectomy (RT).

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm * Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm * Participants with high cosmetic expectations * Participants underwent robotic thyroidectomy without open conversion Exclusion Criteria: * Participants with history of neck surgery or radiation * Participants with vocal fold fixation by preoperative fibrolaryngoscope * Participants with preoperative examination suggestive of distant invasion * Participants with fusion or fixed of lymph nodes in the neck

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Sixth People's Hospital Shanghai China Recruiting

More Shanghai 6th People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06730321 on ClinicalTrials.gov ↗ ← All trials in China